NO941021L - 10-desacetoksytaksolderivater - Google Patents

10-desacetoksytaksolderivater

Info

Publication number
NO941021L
NO941021L NO941021A NO941021A NO941021L NO 941021 L NO941021 L NO 941021L NO 941021 A NO941021 A NO 941021A NO 941021 A NO941021 A NO 941021A NO 941021 L NO941021 L NO 941021L
Authority
NO
Norway
Prior art keywords
opt
aryl
protected
alkyl
desacetoksytaksolderivater
Prior art date
Application number
NO941021A
Other languages
English (en)
Other versions
NO941021D0 (no
NO304740B1 (no
Inventor
Robert A Holton
Shu-Hui Chen
Vittorio Farina
Original Assignee
Univ Florida State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State filed Critical Univ Florida State
Publication of NO941021D0 publication Critical patent/NO941021D0/no
Publication of NO941021L publication Critical patent/NO941021L/no
Publication of NO304740B1 publication Critical patent/NO304740B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Water Treatment By Electricity Or Magnetism (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO934469A 1991-09-23 1994-03-22 10-desacetoksytaxolderivater NO304740B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76380591A 1991-09-23 1991-09-23
US90040892A 1992-06-18 1992-06-18
PCT/US1992/007935 WO1993006093A1 (en) 1991-09-23 1992-09-22 10-desacetoxytaxol derivatives

Publications (3)

Publication Number Publication Date
NO941021D0 NO941021D0 (no) 1994-03-22
NO941021L true NO941021L (no) 1994-05-20
NO304740B1 NO304740B1 (no) 1999-02-08

Family

ID=27117344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934469A NO304740B1 (no) 1991-09-23 1994-03-22 10-desacetoksytaxolderivater

Country Status (15)

Country Link
EP (1) EP0642503B1 (no)
JP (1) JP3304088B2 (no)
KR (1) KR100239201B1 (no)
AT (1) ATE187170T1 (no)
AU (1) AU663732B2 (no)
CA (1) CA2119363C (no)
CZ (1) CZ287609B6 (no)
DE (1) DE69230379T2 (no)
DK (1) DK0642503T3 (no)
ES (1) ES2141727T3 (no)
FI (1) FI112479B (no)
HU (1) HU225474B1 (no)
NO (1) NO304740B1 (no)
UA (1) UA39860C2 (no)
WO (1) WO1993006093A1 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998656A (en) 1991-09-23 1999-12-07 Florida State University C10 tricyclic taxanes
US5294637A (en) * 1992-07-01 1994-03-15 Bristol-Myers Squibb Company Fluoro taxols
ES2211861T3 (es) * 1992-07-01 2004-07-16 Bristol-Myers Squibb Company 7,8-ciclopropataxanos de accion antitumoral.
US5681714A (en) * 1992-07-30 1997-10-28 Mount Sinai Hospital Corporation Nucleic acid encoding tek receptor tyrosine kinase
EP0582469A2 (en) * 1992-08-06 1994-02-09 Wisconsin Alumni Research Foundation Process for preparing taxol-type compound from beta-lactam precursors
CA2100808A1 (en) * 1992-10-01 1994-04-02 Vittorio Farina Deoxy paclitaxels
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
US5646176A (en) * 1992-12-24 1997-07-08 Bristol-Myers Squibb Company Phosphonooxymethyl ethers of taxane derivatives
IL108443A0 (en) * 1993-01-29 1994-04-12 Univ Florida State C7 taxane derivatives and pharmaceutical compositions containing them
ZA94128B (en) * 1993-02-01 1994-08-19 Univ New York State Res Found Process for the preparation of taxane derivatives and betalactam intermediates therefor
US5703247A (en) * 1993-03-11 1997-12-30 Virginia Tech Intellectual Properties, Inc. 2-Debenzoyl-2-acyl taxol derivatives and methods for making same
ATE284689T1 (de) * 1993-03-22 2005-01-15 Univ Florida State Pharmazeutische zusammenstellungen enthaltende eine furyl oder thienyl substituierte seitenkette
EP1155689B1 (en) 1993-07-19 2006-09-20 Angiotech Pharmaceuticals, Inc. Anti-angiogenic stents and methods of their preparation
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
FR2721024B1 (fr) * 1994-06-09 1996-07-12 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
WO1995033740A1 (en) * 1994-06-09 1995-12-14 Daiichi Pharmaceutical Co., Ltd. Deacetoxytaxol derivative
FR2723094A1 (fr) * 1994-07-26 1996-02-02 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US5840929A (en) * 1995-04-14 1998-11-24 Bristol-Myers Squibb Company C4 methoxy ether derivatives of paclitaxel
EP0855909A4 (en) * 1995-09-13 2000-06-07 Univ Florida State TAXANES WITH RADIOSENSITIZING EFFECT AND THEIR PHARMACEUTICAL PREPARATIONS
DE19621311A1 (de) 1996-05-28 1997-12-04 Bayer Ag Substituierte Phenyluracile
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5773464A (en) * 1996-09-30 1998-06-30 Bristol-Myers Squibb Company C-10 epoxy taxanes
US5977386A (en) * 1996-12-24 1999-11-02 Bristol-Myers Squibb Company 6-thio-substituted paclitaxels
US5902822A (en) * 1997-02-28 1999-05-11 Bristol-Myers Squibb Company 7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
US5912264A (en) * 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
US6017935A (en) * 1997-04-24 2000-01-25 Bristol-Myers Squibb Company 7-sulfur substituted paclitaxels
KR101096282B1 (ko) 2009-04-24 2011-12-20 주식회사 삼양제넥스 탁산 유도체를 제조하는 방법
ES2687705T3 (es) 2012-07-19 2018-10-26 Fujifilm Corporation Composición líquida que contiene un principio activo a base de taxano, proceso de producción de la misma y preparación medicinal líquida

Also Published As

Publication number Publication date
FI112479B (fi) 2003-12-15
JP3304088B2 (ja) 2002-07-22
EP0642503A1 (en) 1995-03-15
AU663732B2 (en) 1995-10-19
HU225474B1 (en) 2006-12-28
EP0642503B1 (en) 1999-12-01
CA2119363C (en) 2001-07-17
ATE187170T1 (de) 1999-12-15
FI941324L (fi) 1994-03-22
CZ66194A3 (en) 1995-07-12
DE69230379T2 (de) 2000-05-25
EP0642503A4 (en) 1994-07-07
DK0642503T3 (da) 2000-05-22
HUT68422A (en) 1995-04-26
WO1993006093A1 (en) 1993-04-01
JPH07502981A (ja) 1995-03-30
NO941021D0 (no) 1994-03-22
AU2692692A (en) 1993-04-27
DE69230379D1 (de) 2000-01-05
NO304740B1 (no) 1999-02-08
CA2119363A1 (en) 1993-04-01
FI941324A0 (fi) 1994-03-22
UA39860C2 (uk) 2001-07-16
CZ287609B6 (cs) 2001-01-17
KR100239201B1 (ko) 2000-02-01
ES2141727T3 (es) 2000-04-01
HU9400832D0 (en) 1994-06-28

Similar Documents

Publication Publication Date Title
NO941021D0 (no) 10-desacetoksytaksolderivater
FI970246A7 (fi) Dihydrobentsofuraanit
DE69621180D1 (de) 2,2-Difluor-3-Carbamoylribosesulfonat-Verbindungen und Verfahren zur Herstellung von Beta-Nukleosiden
DE59703471D1 (de) Betain-geminitenside auf der basis von aminen
NZ332762A (en) Isobutylgaba and its derivatives for the treatment of pain
FI952423A0 (fi) Aniliinit mineraaliöljyjen merkkiaineina
PL339701A1 (en) Acylosulphamoybenzamides, crop protection products containing them and method of obtaining such crop protection products
HU9904389D0 (en) Pyridine carboxylic acid derivatives and their salts, antibacterial agent comrising the same
DE69206274D1 (de) 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten.
ATE251153T1 (de) Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung
DK429089A (da) Alkylbenzylaminer
ATE168105T1 (de) Melamine derivate zur verwendung in der behandlung von krebs
MX9203845A (es) Nuevos benzomorfanos, procedimieto para su preparacion y composiciones farmaceuticas que los contienen.
GR3020407T3 (en) Arylkalkyl-amines and -amides having anticonvulsant and neuroprotective properties
CZ119595A3 (en) Cyclohexane derivatives and their use
ES488134A1 (es) Un procedimiento para la preparacion de derivados de 6,7- benzomorfan
FI822950A0 (fi) Aktiv kombination av kitasamycin och kinoxalindi-n-oxider
ES2164665T3 (es) Inhibidores de proteasas retrovirales.